-
2
-
-
79952514300
-
Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia
-
Rizzo M, Battista Rini G. Ezetimibe, cardiovascular risk and atherogenic dyslipidaemia. Arch Med Sci 2011; 7: 5-7.
-
(2011)
Arch Med Sci
, vol.7
, pp. 5-7
-
-
Rizzo, M.1
Battista Rini, G.2
-
3
-
-
0032966298
-
Systematic review on the risk and benefit of different cholesterol- lowering interventions
-
Bucher HC, Griffith LE, Guyatt GH. Systematic review on the risk and benefit of different colesterol-lowering interventions. Arterioscler Thromb Vasc Biol 1999; 19: 187-95. (Pubitemid 29072729)
-
(1999)
Arteriosclerosis, Thrombosis, and Vascular Biology
, vol.19
, Issue.2
, pp. 187-195
-
-
Bucher, H.C.1
Griffith, L.E.2
Guyatt, G.H.3
-
4
-
-
0037414088
-
Antioxidants, statins, and atherosclerosis
-
Gotto AM. Antioxidants, statins, and atherosclerosis. J Am Coll Cardiol 2003; 41: 1205-10.
-
(2003)
J Am Coll Cardiol
, vol.41
, pp. 1205-1210
-
-
Gotto, A.M.1
-
5
-
-
33750606896
-
Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention
-
DOI 10.1097/01.fjc.0000246150.52382.07, PII 0000534420061000000002
-
Kowalski J, Barylski M, Banach M, Grycewicz J, Irzmański R, Pawlicki L. Neutrophil superoxide anion generation during atorvastatin and fluvastatin therapy used in coronary heart disease primary prevention. J Cardiovasc Pharmacol 2006; 48: 143-7. (Pubitemid 44691215)
-
(2006)
Journal of Cardiovascular Pharmacology
, vol.48
, Issue.4
, pp. 143-147
-
-
Kowalski, J.1
Barylski, M.2
Banach, M.3
Grycewicz, J.4
Irzmanski, R.5
Pawlicki, L.6
-
6
-
-
67649615556
-
Effects of atorvastatin on vascular intimal hyperplasia: An experimental rodent model
-
Aydin U, Ugurlucan M, Gungor F, et al. Effects of atorvastatin on vascular intimal hyperplasia: an experimental rodent model. Angiology 2009; 60: 370-7.
-
(2009)
Angiology
, vol.60
, pp. 370-377
-
-
Aydin, U.1
Ugurlucan, M.2
Gungor, F.3
-
7
-
-
80052569582
-
Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome
-
Mieczkowska J, Mosiewicz J, Barud W, Kwaśniewski W. Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome. Arch Med Sci 2011; 7: 634-41.
-
(2011)
Arch Med Sci
, vol.7
, pp. 634-641
-
-
Mieczkowska, J.1
Mosiewicz, J.2
Barud, W.3
Kwaśniewski, W.4
-
8
-
-
84860129617
-
The role of Porphyromonas gingivalis in atherosclerosis
-
Szulc M, Radwan-Oczko M. The role of Porphyromonas gingivalis in atherosclerosis. Kardiochir Torakochi 2012; 9: 100-5.
-
(2012)
Kardiochir Torakochi
, vol.9
, pp. 100-105
-
-
Szulc, M.1
Radwan-Oczko, M.2
-
9
-
-
71549121695
-
Treating inflammation in atherosclerotic cardiovascular disease:Emerging therapies
-
Klingenberg R, Hansson GK. Treating inflammation in atherosclerotic cardiovascular disease:emerging therapies. Eur Heart J 2009; 30: 2838-44.
-
(2009)
Eur Heart J
, vol.30
, pp. 2838-2844
-
-
Klingenberg, R.1
Hansson, G.K.2
-
10
-
-
65549134708
-
HSP 70 and atherosclerosis: Protector or activator?
-
Bielecka-Dabrowa A, Barylski M, Mikhailidis DP, Rysz J, Banach M. HSP 70 and atherosclerosis: protector or activator? Expert Opin Ther Targets 2009; 13: 307-17.
-
(2009)
Expert Opin Ther Targets
, vol.13
, pp. 307-317
-
-
Bielecka-Dabrowa, A.1
Barylski, M.2
Mikhailidis, D.P.3
Rysz, J.4
Banach, M.5
-
11
-
-
33644888267
-
Chemokines as potential therapeutic targets in atherosclerosis
-
Sheikine YA, Hansson GK. Chemokines as potential therapeutic targets in atherosclerosis. Current Drug Targets 2006; 7: 13-28.
-
(2006)
Current Drug Targets
, vol.7
, pp. 13-28
-
-
Sheikine, Y.A.1
Hansson, G.K.2
-
12
-
-
47849091670
-
Antiplatelet drugs in cardiological practice: Established strategies and new developments
-
Krotz F, Sohn HY, Klauss V. Antiplatelet drugs in cardiological practice: established strategies and new developments. Vasc Health Risk Manag 2008; 4: 637-45. (Pubitemid 352037921)
-
(2008)
Vascular Health and Risk Management
, vol.4
, Issue.3
, pp. 637-645
-
-
Krotz, F.1
Sohn, H.-Y.2
Klauss, V.3
-
13
-
-
0031832030
-
Antiplatelet therapy in atherosclerotic cardiovascular disease
-
Gonzalez ER. Antiplatelet therapy in atherosclerotic cardiovascular disease. Clin Ther 1998; 20: B18-41. (Pubitemid 128646607)
-
(1998)
Clinical Therapeutics
, vol.20
, Issue.SUPPL.2
-
-
Gonzalez, E.R.1
-
14
-
-
84860315873
-
Apolipoprotein E knockout mice: An experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative anti-atherogenic properties of drugs
-
Jawień J, Olszanecki R, Nowak B, Marcinkiewicz J. Apolipoprotein E knockout mice: an experimental model to study inflammatory mechanisms of atherosclerosis and to screen a putative anti-atherogenic properties of drugs. Centr Eur J Immunol 2012; 37: 36-44.
-
(2012)
Centr Eur J Immunol
, vol.37
, pp. 36-44
-
-
Jawień, J.1
Olszanecki, R.2
Nowak, B.3
Marcinkiewicz, J.4
-
15
-
-
84861585543
-
Dysfunctional HDL: A novel important diagnostic and therapeutic target in cardiovascular disease?
-
Otocka-Kmiecik A, Mikhailidis DP, Nicholls SJ, Davidson M, Rysz J, Banach M. Dysfunctional HDL: a novel important diagnostic and therapeutic target in cardiovascular disease? Prog Lipid Res 2012; 51: 314-24.
-
(2012)
Prog Lipid Res
, vol.51
, pp. 314-324
-
-
Otocka-Kmiecik, A.1
Mikhailidis, D.P.2
Nicholls, S.J.3
Davidson, M.4
Rysz, J.5
Banach, M.6
-
16
-
-
66349092844
-
Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells
-
Ou HC, Lee WJ, Lee IT, et al. Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells. J Appl Physiol 2009; 106: 1674-85.
-
(2009)
J Appl Physiol
, vol.106
, pp. 1674-1685
-
-
Ou, H.C.1
Lee, W.J.2
Lee, I.T.3
-
17
-
-
34248218053
-
Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients
-
DOI 10.1016/j.atherosclerosis.2007.02.021, PII S0021915007001219
-
Rodríguez M, Ringstad L, Schäfer P, et al. Reduction of atherosclerotic nanoplaque formation and size by Ginkgo biloba (EGb 761) in cardiovascular high-risk patients. Atherosclerosis 2007; 192: 438-44. (Pubitemid 46726344)
-
(2007)
Atherosclerosis
, vol.192
, Issue.2
, pp. 438-444
-
-
Rodriguez, M.1
Ringstad, L.2
Schafer, P.3
Just, S.4
Hofer, H.W.5
Malmsten, M.6
Siegel, G.7
-
18
-
-
34548380968
-
Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis
-
DOI 10.1007/s10354-007-0426-6
-
Siegel G, Schäfer P, Winkler K, Malmsten M. Ginkgo biloba (EGb 761) in arteriosclerosis prophylaxis. Wien Med Wochenschr 2007; 157: 288-94. (Pubitemid 47356251)
-
(2007)
Wiener Medizinische Wochenschrift
, vol.157
, Issue.13-14
, pp. 288-294
-
-
Siegel, G.1
Schafer, P.2
Winkler, K.3
Malmsten, M.4
-
19
-
-
0032732971
-
Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells
-
DOI 10.1016/S0306-3623(99)00027-0, PII S0306362399000270
-
Wei Z, Peng Q, Lau BH, Shah V. Ginkgo biloba inhibits hydrogen peroxide-induced activation of nuclear factor kappa B in vascular endothelial cells. Gen Pharmacol 1999; 33: 369-75. (Pubitemid 29507455)
-
(1999)
General Pharmacology
, vol.33
, Issue.5
, pp. 369-375
-
-
Wei, Z.1
Peng, Q.2
Lau, B.H.S.3
Shah, V.4
-
20
-
-
0041689955
-
Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells
-
Chen JW, Chen YH, Lin FY, Chen YL, Lin SJ. Ginkgo biloba extract inhibits tumor necrosis factor-alpha-induced reactive oxygen species generation, transcription factor activation, and cell adhesion molecule expression in human aortic endothelial cells. Arterioscler Thromb Vasc Biol 2003; 23: 1559-66.
-
(2003)
Arterioscler Thromb Vasc Biol
, vol.23
, pp. 1559-1566
-
-
Chen, J.W.1
Chen, Y.H.2
Lin, F.Y.3
Chen, Y.L.4
Lin, S.J.5
-
21
-
-
22144456429
-
Expression of pro-inflammatory and anti-inflammatory cytokines in brain of atherosclerotic rats and effects of Ginkgo biloba extract
-
DOI 10.1111/j.1745-7254.2005.00106.x
-
Jiao YB, Rui YC, Li TJ, Yang PY, Qiu Y. Expression of pro-inflammatory and anti-inflammatory cytokines in brain of atherosclerotic rats and effects of Ginkgo biloba extract. Acta Pharmacol Sin 2005; 26: 835-9. (Pubitemid 40978765)
-
(2005)
Acta Pharmacologica Sinica
, vol.26
, Issue.7
, pp. 835-839
-
-
Jiao, Y.-B.1
Rui, Y.-C.2
Li, T.-J.3
Yang, P.-Y.4
Qiu, Y.5
-
22
-
-
58149147399
-
The standardized Ginkgo biloba extract Egb-761 protects vascular endothelium exposed to oxidized low density lipoproteins
-
Noisy-le-grand
-
Pierre SV, Lesnik P, Moreau M, et al. The standardized Ginkgo biloba extract Egb-761 protects vascular endothelium exposed to oxidized low density lipoproteins. Cell Mol Biol (Noisy-le-grand) 2008; 54 Suppl: OL1032-42.
-
(2008)
Cell Mol Biol
, vol.54
, Issue.SUPPL.
-
-
Pierre, S.V.1
Lesnik, P.2
Moreau, M.3
-
23
-
-
42949167795
-
Inhibitory effect of Ginkgo Biloba extract on hyperhomocysteinemia- induced intimal thickening in rabbit abdominal aorta after balloon injury
-
DOI 10.1002/ptr.2353
-
Liu F, Zhang J, Yu S, et al. Inhibitory effect of Ginkgo biloba extract on hyperhomocysteinemia-induced intimal thickening in rabbit abdominal aorta after balloon injury. Phytother Res 2008; 22: 506-10. (Pubitemid 351613416)
-
(2008)
Phytotherapy Research
, vol.22
, Issue.4
, pp. 506-510
-
-
Liu, F.1
Zhang, J.2
Yu, S.3
Wang, R.4
Wang, B.5
Lai, L.6
Yin, H.7
Liu, G.8
-
24
-
-
59649089829
-
Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells
-
Liu HJ, Wang XL, Zhang L, et al. Inhibitions of vascular endothelial growth factor expression and foam cell formation by EGb 761, a special extract of Ginkgo biloba, in oxidatively modified low-density lipoprotein-induced human THP-1 monocytes cells. Phytomedicine 2009; 16: 138-45.
-
(2009)
Phytomedicine
, vol.16
, pp. 138-145
-
-
Liu, H.J.1
Wang, X.L.2
Zhang, L.3
-
25
-
-
5444245567
-
Inhibitory effect of extracts of Ginkgo biloba leaves on VEGF-induced hyperpermeability of bovine coronary endothelial cells in vitro
-
Qiu Y, Rui YC, Li TJ, Zhang L, Yao PY. Inhibitory effect of extracts of Ginkgo biloba leaves on VEGF-induced hyperpermeability of bovine coronary endothelial cells in vitro. Acta Pharmacol Sin 2004; 25: 1306-11. (Pubitemid 39361802)
-
(2004)
Acta Pharmacologica Sinica
, vol.25
, Issue.10
, pp. 1306-1311
-
-
Qiu, Y.1
Rui, Y.-C.2
Li, T.-J.3
Zhang, L.4
Yang, P.-Y.5
-
26
-
-
78149337025
-
EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: Role of haem oxygenase-1
-
Tsai JY, Su KH, Shyue SK, et al. EGb761 ameliorates the formation of foam cells by regulating the expression of SR-A and ABCA1: role of haem oxygenase-1. Cardiovasc Res 2010; 88: 415-23.
-
(2010)
Cardiovasc Res
, vol.88
, pp. 415-423
-
-
Tsai, J.Y.1
Su, K.H.2
Shyue, S.K.3
-
27
-
-
33749531597
-
Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice
-
DOI 10.1161/CIRCULATIONAHA.106.643841, PII 0000301720061003000015
-
Secchiero P, Candido R, Corallini F, et al. Systemic tumor necrosis factor-related apoptosis-inducing ligand delivery shows antiatherosclerotic activity in apolipoprotein E-null diabetic mice. Circulation 2006; 114: 1522-30. (Pubitemid 44527008)
-
(2006)
Circulation
, vol.114
, Issue.14
, pp. 1522-1530
-
-
Secchiero, P.1
Candido, R.2
Corallini, F.3
Zacchigna, S.4
Toffoli, B.5
Rimondi, E.6
Fabris, B.7
Giacca, M.8
Zauli, G.9
-
28
-
-
1842538570
-
Irbesartan but Not Amlodipine Suppresses Diabetes-Associated Atherosclerosis
-
DOI 10.1161/01.CIR.0000124061.78478.94
-
Candido R, Allen TJ, Lassila M, et al. Irbesartan but not amlodipine suppresses diabetes associated atherosclerosis. Circulation 2004; 109: 1536-42. (Pubitemid 38420183)
-
(2004)
Circulation
, vol.109
, Issue.12
, pp. 1536-1542
-
-
Candido, R.1
Allen, T.J.2
Lassila, M.3
Cao, Z.4
Thallas, V.5
Cooper, M.E.6
Jandeleit-Dahm, K.A.7
-
29
-
-
77950540738
-
Dysferlin overexpression in skeletal muscle produces a progressive myopathy
-
Glover LE, Newton K, Krishnan G, et al. Dysferlin overexpression in skeletal muscle produces a progressive myopathy. Ann Neurol 2010; 67: 384-93.
-
(2010)
Ann Neurol
, vol.67
, pp. 384-393
-
-
Glover, L.E.1
Newton, K.2
Krishnan, G.3
-
30
-
-
36749079217
-
Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: Implications for fatigue
-
DOI 10.1016/j.bbi.2007.06.013, PII S0889159107001274
-
Davis MC, Zautra AJ, Younger J, Motivala SJ, Attrep J, Irwin MR. Chronic stress and regulation of cellular markers of inflammation in rheumatoid arthritis: implications for fatigue. Brain Behav Immun 2008; 22: 24-32. (Pubitemid 350216361)
-
(2008)
Brain, Behavior, and Immunity
, vol.22
, Issue.1
, pp. 24-32
-
-
Davis, M.C.1
Zautra, A.J.2
Younger, J.3
Motivala, S.J.4
Attrep, J.5
Irwin, M.R.6
-
31
-
-
17044393415
-
Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits
-
Wang LH, Chen JZ, Sun YL, et al. Statins reduce connexin40 and connexin43 expression in atherosclerotic aorta of rabbits. Int J Cardiol 2005; 100: 467-75.
-
(2005)
Int J Cardiol
, vol.100
, pp. 467-475
-
-
Wang, L.H.1
Chen, J.Z.2
Sun, Y.L.3
-
32
-
-
0037465360
-
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice
-
DOI 10.1161/01.CIR.0000051364.70064.D1
-
Kwak BR, Veillard N, Pelli G, et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003; 107: 1033-9. (Pubitemid 36258728)
-
(2003)
Circulation
, vol.107
, Issue.7
, pp. 1033-1039
-
-
Kwak, B.R.1
Veillard, N.2
Pelli, G.3
Mulhaupt, F.4
James, R.W.5
Chanson, M.6
Mach, F.7
-
33
-
-
0031049372
-
Connexin43 gene expression in the rabbit arterial wall: Effects of hypercholesterolemia, balloon injury and their combination
-
Polacek D, Bech F, McKinsey JF, Davies PF. Connexin43 gene expression in the rabbit arterial wall: effects of hypercholesterolemia, balloon injury and their combination. J Vasc Res 1997; 34: 19-30. (Pubitemid 27105911)
-
(1997)
Journal of Vascular Research
, vol.34
, Issue.1
, pp. 19-30
-
-
Polacek, D.1
Bech, F.2
McKinsey, J.F.3
Davies, P.F.4
-
34
-
-
0029161009
-
Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis
-
Blackburn JP, Peters NS, Yeh HI, Rothery S, Green CR, Severs NJ. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1219-28.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1219-1228
-
-
Blackburn, J.P.1
Peters, N.S.2
Yeh, H.I.3
Rothery, S.4
Green, C.R.5
Severs, N.J.6
-
35
-
-
79957954733
-
EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes
-
Lim S, Yoon JW, Kang SM, et al. EGb761, a Ginkgo biloba extract, is effective against atherosclerosis in vitro, and in a rat model of type 2 diabetes. PLoS One 2011; 6: e20301.
-
(2011)
PLoS One
, vol.6
-
-
Lim, S.1
Yoon, J.W.2
Kang, S.M.3
-
36
-
-
0029161009
-
Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis
-
Blackburn JP, Peters NS, Yeh HI, Rothery S, Green CR, Severs NJ. Upregulation of connexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995; 15: 1219-28.
-
(1995)
Arterioscler Thromb Vasc Biol
, vol.15
, pp. 1219-1228
-
-
Blackburn, J.P.1
Peters, N.S.2
Yeh, H.I.3
Rothery, S.4
Green, C.R.5
Severs, N.J.6
-
37
-
-
0037465360
-
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice
-
DOI 10.1161/01.CIR.0000051364.70064.D1
-
Kwak BR, Veillard N, Pelli G, et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003; 107: 1033-9. (Pubitemid 36258728)
-
(2003)
Circulation
, vol.107
, Issue.7
, pp. 1033-1039
-
-
Kwak, B.R.1
Veillard, N.2
Pelli, G.3
Mulhaupt, F.4
James, R.W.5
Chanson, M.6
Mach, F.7
-
39
-
-
0037465360
-
Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice
-
DOI 10.1161/01.CIR.0000051364.70064.D1
-
Kwak BR, Veillard N, Pelli G, et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003; 107: 1033-9. (Pubitemid 36258728)
-
(2003)
Circulation
, vol.107
, Issue.7
, pp. 1033-1039
-
-
Kwak, B.R.1
Veillard, N.2
Pelli, G.3
Mulhaupt, F.4
James, R.W.5
Chanson, M.6
Mach, F.7
-
40
-
-
31144447355
-
Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain
-
DOI 10.1142/S0192415X05003430, PII S0192415X05003430
-
Li Z, Lin XM, Gong PL, Zeng FD, Du GH. Effects of Gingko biloba extract on gap junction changes induced by reperfusion/reoxygenation after ischemia/hypoxia in rat brain. Am J Chin Med 2005; 33: 923-34. (Pubitemid 43124517)
-
(2005)
American Journal of Chinese Medicine
, vol.33
, Issue.6
, pp. 923-934
-
-
Li, Z.1
Lin, X.-M.2
Gong, P.-L.3
Zeng, F.-D.4
Du, G.-H.5
|